| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 7,500 | $23.74 | $178,027.50 | -5.4% | |
| Sep 12, 2019 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 100,000 | $22.68 | $2,268,220.00 | -12.2% | |
| Sep 12, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Hudson Executive Capital LP49 | Director | Sell | 1,312 | $60.06 | $78,798.94 | - | |
| Sep 12, 2019 | ORGO Organogenesis Holdings Inc. | Avista Capital Managing Member Iv, LLC | Director, 10% Owner | Buy | 860,900 | $5.99 | $5,155,772.37 | +2.3% | |
| Sep 12, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 9,446 | $5.16 | $48,715.90 | -6.4% | |
| Sep 11, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Zhang Jack Y.45 | CEO &Chief Scientific Officer | Sell | 300,000 | $20.82 | $6,246,000.00 | -4.1% | |
| Sep 11, 2019 | ELAN Elanco Animal Health Inc | Kochevar Deborah Turner | Director | Buy | 1,000 | $27.95 | $27,950.00 | +35.9% | |
| Sep 11, 2019 | ORGO Organogenesis Holdings Inc. | MacKie Wayne D | Director | Buy | 13,010 | $5.30 | $69,017.27 | +5.1% | |
| Sep 10, 2019 | SNY Sanofi | Sanofi | 10% Owner | Sell | 172,904 | $281.15 | $48,611,803.99 | -0.8% | |
| Sep 10, 2019 | ORGO Organogenesis Holdings Inc. | Avista Capital Managing Member Iv, LLC | Director, 10% Owner | Buy | 537,000 | $5.18 | $2,782,529.30 | +1.0% | |
| Sep 10, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 46,000 | $0.41 | $18,875.00 | - | |
| Sep 9, 2019 | HROW Harrow, Inc. | Kammer Robert J | - | Sell | 6,500 | $5.67 | $36,855.00 | -0.8% | |
| Sep 9, 2019 | EBS Emergent Biosolutions Inc. | Zoon Kathryn C62 | Director | Sell | 1,509 | $56.12 | $84,692.02 | -6.6% | |
| Sep 9, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Daniell Richard | Exec. VP, European Commercial | Sell | 333 | $7.16 | $2,384.28 | -47.8% | |
| Sep 6, 2019 | ORGO Organogenesis Holdings Inc. | Ades Alan A. | Director, 10% Owner | Buy | 10,000 | $5.03 | $50,274.00 | - | |
| Sep 6, 2019 | ORGO Organogenesis Holdings Inc. | Nussdorf Glenn H75 | Director, 10% Owner | Buy | 10,000 | $5.03 | $50,274.00 | - | |
| Sep 6, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Liawatidewi Yakob47 | SVP Corp Admin Center | Sell | 3,910 | $21.65 | $84,638.41 | -34.8% | |
| Sep 6, 2019 | ESPR Esperion Therapeutics, Inc. | Mayleben Timothy M | President &CEO | Buy | 7,500 | $34.55 | $259,106.60 | +3.4% | |
| Sep 5, 2019 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 100,000 | $20.18 | $2,017,830.00 | -12.2% | |
| Sep 5, 2019 | LLY Eli Lilly & Co | Fry Stephen F | SVP, Hr &Diversity | Sell | 9,452 | $115.00 | $1,086,980.00 | -8.6% | |
| Sep 5, 2019 | ORGO Organogenesis Holdings Inc. | Ades Alan A. | Director, 10% Owner | Buy | 105,100 | $4.50 | $473,209.00 | - | |
| Sep 5, 2019 | ORGO Organogenesis Holdings Inc. | Avista Capital Managing Member Iv, LLC | Director, 10% Owner | Buy | 577,600 | $4.84 | $2,797,550.56 | +1.1% | |
| Sep 5, 2019 | ORGO Organogenesis Holdings Inc. | Nussdorf Glenn H75 | Director, 10% Owner | Buy | 105,100 | $4.50 | $473,209.00 | - | |
| Sep 4, 2019 | ELAN Elanco Animal Health Inc | Young Todd S. | See Remarks | Buy | 10,000 | $26.57 | $265,700.00 | +53.0% | |
| Sep 4, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 5,604 | $20.60 | $115,464.82 | -3.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.